Bank of America’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.05M Buy
497,619
+246,048
+98% +$2M ﹤0.01% 3492
2025
Q1
$1.97M Buy
251,571
+91,426
+57% +$718K ﹤0.01% 3939
2024
Q4
$2.38M Buy
160,145
+19,232
+14% +$286K ﹤0.01% 3630
2024
Q3
$2.15M Sell
140,913
-609
-0.4% -$9.31K ﹤0.01% 3798
2024
Q2
$2.16M Sell
141,522
-8,030
-5% -$122K ﹤0.01% 3735
2024
Q1
$2.82M Sell
149,552
-15,340
-9% -$290K ﹤0.01% 3511
2023
Q4
$3.15M Sell
164,892
-27,919
-14% -$533K ﹤0.01% 3277
2023
Q3
$3.46M Buy
192,811
+4,790
+3% +$86K ﹤0.01% 3119
2023
Q2
$3.82M Sell
188,021
-961,197
-84% -$19.5M ﹤0.01% 3078
2023
Q1
$21M Buy
1,149,218
+1,010,207
+727% +$18.4M ﹤0.01% 1804
2022
Q4
$2.87M Sell
139,011
-10,466
-7% -$216K ﹤0.01% 3377
2022
Q3
$3.91M Buy
149,477
+67,489
+82% +$1.77M ﹤0.01% 3043
2022
Q2
$2.08M Sell
81,988
-55,473
-40% -$1.41M ﹤0.01% 3674
2022
Q1
$4.34M Buy
137,461
+39,989
+41% +$1.26M ﹤0.01% 3277
2021
Q4
$3.95M Buy
97,472
+28,802
+42% +$1.17M ﹤0.01% 3333
2021
Q3
$2.39M Buy
68,670
+31,883
+87% +$1.11M ﹤0.01% 3649
2021
Q2
$1.01M Buy
36,787
+4,770
+15% +$131K ﹤0.01% 4235
2021
Q1
$899K Sell
32,017
-4,380
-12% -$123K ﹤0.01% 4340
2020
Q4
$945K Buy
36,397
+6,879
+23% +$179K ﹤0.01% 3921
2020
Q3
$506K Sell
29,518
-7,427
-20% -$127K ﹤0.01% 4144
2020
Q2
$914K Buy
36,945
+16,194
+78% +$401K ﹤0.01% 3727
2020
Q1
$288K Sell
20,751
-21,912
-51% -$304K ﹤0.01% 4333
2019
Q4
$431K Buy
42,663
+7,488
+21% +$75.6K ﹤0.01% 4387
2019
Q3
$321K Sell
35,175
-10,880
-24% -$99.3K ﹤0.01% 4613
2019
Q2
$366K Buy
46,055
+18,419
+67% +$146K ﹤0.01% 4554
2019
Q1
$346K Buy
27,636
+6,825
+33% +$85.4K ﹤0.01% 4536
2018
Q4
$225K Buy
20,811
+18,240
+709% +$197K ﹤0.01% 4737
2018
Q3
$36K Buy
2,571
+1,891
+278% +$26.5K ﹤0.01% 5599
2018
Q2
$9K Sell
680
-1,882
-73% -$24.9K ﹤0.01% 5939
2018
Q1
$40K Buy
+2,562
New +$40K ﹤0.01% 5384